Shanghai Laishi was established in 1988 and listed on the Shenzhen Stock Exchange in 2008 (stock code: 002252). It is an important strategic layout of Haier Group's big health sector Yingkang's life in the biotechnology industry. The production scale of blood products ranks among the top in the country. It is a domestic In the same industry, a blood product manufacturer with high comprehensive utilization rate of plasma, complete product structure and variety, and leading quality. Since its establishment, Shanghai RAAS has always adhered to the quality policy of "safety, high quality and high efficiency". It has 6 blood product production bases and 55 plasma collection stations in Shanghai, ...
